Search research articles
Contact Us
Filters
Showing results (11-20 of 45) with videos related to
Page
of 5
Sort By:
Oncology Research
|
January 1, 1997
Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells
B A Spengler, D L Lazarova, R A Ross, et al.
In Vitro
|
July 1, 1981
The fine structure of continuous human neuroblastoma lines SK-N-SH, SK-N-BE(2), and SK-N-MC
E N Barnes, J L Biedler, B A Spengler, et al.
Oncogene
|
November 10, 2005
Loss of one HuD allele on chromosome #1p selects for amplification of the N-myc proto-oncogene in human neuroblastoma cells
K B Grandinetti, B A Spengler, J L Biedler, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 1983
Specific DNA sequence amplification in human neuroblastoma cells
K T Montgomery, J L Biedler, B A Spengler, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1986
Epidermal growth factor receptor is increased in multidrug-resistant Chinese hamster and mouse tumor cells
M B Meyers, V J Merluzzi, B A Spengler, et al.
Cancer Research
|
October 1, 1976
Radiation-induced murine leukemia ERLD in cell culture
A M Albrecht, J L Biedler, D J Hutchison, et al.
The Journal of Clinical Investigation
|
April 15, 1997
Gene rearrangement: a novel mechanism for MDR-1 gene activation
L A Mickley, B A Spengler, T A Knutsen, et al.
Cancer Research
|
January 1, 1989
Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages
V Ciccarone, B A Spengler, M B Meyers, et al.
Biochemical Pharmacology
|
July 15, 1987
Sorcin (V19), a soluble acidic calcium-binding protein overproduced in multidrug-resistant cells. Identification of the protein by anti-sorcin antibody
M B Meyers, K A Schneider, B A Spengler, et al.
Journal of Pediatric Surgery
|
September 1, 1991
Multidrug resistance in human neuroblastoma cells
M P LaQuaglia, E B Kopp, B A Spengler, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 45) with videos related to
Sort By:
Page
of 5
Oncology Research
|
January 1, 1997
Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells
B A Spengler, D L Lazarova, R A Ross, et al.
In Vitro
|
July 1, 1981
The fine structure of continuous human neuroblastoma lines SK-N-SH, SK-N-BE(2), and SK-N-MC
E N Barnes, J L Biedler, B A Spengler, et al.
Oncogene
|
November 10, 2005
Loss of one HuD allele on chromosome #1p selects for amplification of the N-myc proto-oncogene in human neuroblastoma cells
K B Grandinetti, B A Spengler, J L Biedler, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 1983
Specific DNA sequence amplification in human neuroblastoma cells
K T Montgomery, J L Biedler, B A Spengler, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1986
Epidermal growth factor receptor is increased in multidrug-resistant Chinese hamster and mouse tumor cells
M B Meyers, V J Merluzzi, B A Spengler, et al.
Cancer Research
|
October 1, 1976
Radiation-induced murine leukemia ERLD in cell culture
A M Albrecht, J L Biedler, D J Hutchison, et al.
The Journal of Clinical Investigation
|
April 15, 1997
Gene rearrangement: a novel mechanism for MDR-1 gene activation
L A Mickley, B A Spengler, T A Knutsen, et al.
Cancer Research
|
January 1, 1989
Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages
V Ciccarone, B A Spengler, M B Meyers, et al.
Biochemical Pharmacology
|
July 15, 1987
Sorcin (V19), a soluble acidic calcium-binding protein overproduced in multidrug-resistant cells. Identification of the protein by anti-sorcin antibody
M B Meyers, K A Schneider, B A Spengler, et al.
Journal of Pediatric Surgery
|
September 1, 1991
Multidrug resistance in human neuroblastoma cells
M P LaQuaglia, E B Kopp, B A Spengler, et al.
Page
of 5